Willenken LLP’s Post

Very important symposium on the latest legal issues compounding, featuring Rachael Pontikes!

The increased focus on business development in law firms goes beyond building skills—it plays a crucial role in partner retention. With the stakes higher than ever, firms are recognizing the need for personalized, relevant, and strategic training to engage attorneys, reduce attrition, and drive business growth. If you haven’t read this insightful Law.com article, featuring expert commentary by Deborah Brightman Farone, I highly recommend it: https://lnkd.in/e5QuZs7x I'm proud to collaborate with the distinguished global leaders on the Furia Rubel International Faculty, who recognize that today’s legal landscape demands more than adaptation—it requires firms to anticipate, innovate, and thrive. #InternationalFaculty #PartnerDevelopment #BusinessOfLaw #LeadershipTraining #LawFirmExcellence #GlobalExpertise

In an article spotlighting Cooley’s 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. Cooley's global life sciences practice spans corporate, litigation, regulatory and intellectual property capabilities, with almost 280 partners, associates, paralegals and other legal professionals attached to life sciences work of some kind across all 19 offices. Learn more here: https://bit.ly/49Kvv8f #lifesciences #leadership #biotech #TeamCooley

Aequo has been shortlisted as the “Ukraine Firm of the Year” by the LMG Life Science Awards 2024 EMEA. We are honoured that the dedicated awards programme has marked our work in life sciences and pharmaceuticals, which have historically been our priority areas. Aequo has strong expertise in the pharmaceutical sector, with a particular focus on IP, antitrust and competition matters, regularly acting for pharma and life sciences companies in IP litigation disputes, prosecuting new patents and trademarks, managing IP portfolios, and advising on every other aspect of the business cycle of a life science product or health care service. The LMG Life Sciences awards look to recognise leading law firms and lawyers specialised in the life sciences industry throughout Europe, the Middle East, and Africa through a deep analysis of the business and legal developments in the sector. The intricacies of life science products require a diverse array of legal expertise across many disciplines. From regulatory approval or patent filing to collaborative transactions or product liabilities, legal practitioners are essential in guiding a product through its life cycle. 

News! Former senior FTC lawyer David B. Schwartz joins our Washington D.C. office as an Antitrust & Competition partner.   David brings extensive knowledge in antitrust law and litigation, leveraging from his experience as a former Lead Investigative Attorney at the FTC.   Previously serving in the commission's Healthcare Division of the Bureau of Competition, he regularly advises on enforcement issues related to pharmaceutical pricing, health information technology conduct, private equity provider acquisitions, and Medicine Modernization Act patent settlements.   Learn more about David here: https://lnkd.in/eZfu8aVd   #Law #Antitrust #Competition #NewHire

🌎 Our world-class Life Sciences M&A Team has been on a tear in the last couple months having completed a trio of BIG deals (links in the comments)… ✅ Represented Deciphera Pharmaceuticals in its $2.4 billion acquisition by ONO Pharmaceutical ✅ Represented Fusion Pharmaceuticals in its $2.4 billion acquisition by AstraZeneca ✅ Represented Mariana Oncology in its $1 billion acquisition by Novartis 🔥M&A is really heating up… and these transactions are complex (and in some cases, groundbreaking) and require highly strategic and deeply knowledgeable counsel to successfully guide them to completion. 🎖️Hats off to the incredible #teams at Goodwin who worked on these deals… and to the Co-Chairs of our Global Life Sciences M&A Practice, Graham Defries, Danielle Lauzon and Robert Masella for their strategic leadership in keeping us at the top of the mountain here! And congratulations to our amazing clients - wouldn’t be here without you! #premiere #lifesciences #legal #strategists #MandA #goodwinlaw

Lawyers and compliance folks, check out this free presentation!

Delighted for #TeamHB Partner Hilary Bricken, who will serve on Law360's Cannabis Editorial Advisory Board for 2024. These boards comprise approximately 10 subject-matter leaders who provide feedback on Law360’s coverage and insight on how best to cover each respective practice area. Read more about Hilary's practice: https://lnkd.in/eeAYe3UV #cannabislaw #legalinsights #Law360

IP Philly Today! Our next session, "Patent Law: Year in Review," was moderated by The Honorable John F. Murphy with panelists John O. Hillman from BakerHostetler, Alison P. Patitucci, Ph.D. from Morgan, Lewis & Bockius LLP, Anthony David Sierra from Akin Gump Strauss Hauer & Feld LLP, and Brianna Vinci from Duane Morris LLP. Major cases such as Amgen v. Sanofi and LKQ Corp. v. GMGlobal Technology, among others, were discussed. #IPPhilly #PatentLaw

The Life Sciences & Pharma IP Litigation 2024 guide has expanded to 18 jurisdictions. The guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations. We thank the editors Nicola Dagg, Daniel Lim, Jin Ooi and Gabriella Bornstein from Kirkland & Ellis for their contributions. View the guide here: https://lnkd.in/eDDcYENN